
ABMD
Healthcare · Healthcare Equipment & Supplies · $17.18B market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2022
EPS trend, 90 days to now · -100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 1, 2022 | Before the open | 1.04 | 1.30 | +25.0% |
| Aug 4, 2022 | Before the open | 1.06 | 1.25 | +17.9% |
| Apr 28, 2022 | Before the open | 1.09 | 1.16 | +6.4% |
| Feb 3, 2022 | Before the open | 0.95 | 1.13 | +18.9% |
| Oct 28, 2021 | Before the open | 0.97 | 1.03 | +6.2% |
| Aug 4, 2021 | After the close | 1.05 | 1.10 | +4.8% |
| Apr 29, 2021 | Before the open | 1.10 | 1.24 | +12.7% |
| Jan 28, 2021 | Before the open | 1.13 | 1.35 | +19.5% |
| Oct 29, 2020 | Before the open | 0.92 | 1.36 | +47.8% |
| Aug 6, 2020 | Before the open | 0.29 | 0.98 | +237.9% |
| Apr 30, 2020 | Before the open | 0.94 | 0.70 | -25.5% |
| Feb 6, 2020 | Before the open | 1.09 | 1.51 | +38.5% |
| Oct 31, 2019 | Before the open | 0.93 | 0.28 | -69.9% |
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well…
| Aug 1, 2019 | Before the open | 0.97 | 1.93 | +99.0% |
| May 2, 2019 | Before the open | 1.08 | 1.09 | +0.9% |
| Jan 31, 2019 | Before the open | 0.94 | 0.97 | +3.2% |
| Nov 1, 2018 | Before the open | 0.74 | 1.09 | +47.3% |
| Jul 26, 2018 | Before the open | 0.82 | 1.95 | +137.8% |
| May 3, 2018 | Before the open | 0.64 | 0.80 | +25.0% |
| Feb 1, 2018 | Before the open | 0.51 | 0.29 | -43.1% |